DLA contracts Steris to supply patient monitoring systems

DLA contracts Steris to supply patient monitoring systems | Quest Diagnostics to buy clinical labs in Indiana | BARDA awards $629K to MBio for COVID-19 antibody test

Created for majed2aboshddad.majed@blogger.com | Web Version

June 25, 2020

News for medical technology professionals

Top Story

DLA contracts Steris to supply patient monitoring systems

The Defense Logistics Agency has given a 10-year indefinite delivery/indefinite quantity contract worth $225 million to Steris to supply military and federal civilian agencies with patient monitoring systems as well as capital equipment and accessories.

Full Story: GovConWire (6/24)

	Critical Requirements to Stay Compliant When it comes to adhering to medical device regulations, companies must be wary of "business-as-usual" practices. The processes that have worked for decades are fast becoming inadequate. Download this whitepaper to learn how a high-quality RIM system can lead to success in a complex global regulatory environment.

Business & Market Trends

Quest Diagnostics to buy clinical labs in Indiana

Quest Diagnostics is purchasing its joint venture partner interests in Mid America Clinical Laboratories for an undisclosed amount, taking full control of the business. MACL is the largest independent clinical lab in Indiana.

Full Story: 360Dx (tiered subscription model) (6/24)

BARDA awards $629K to MBio for COVID-19 antibody test

The Biomedical Advanced Research and Development Authority has given $629,595 to MBio Diagnostics to aid in the development and commercialization of its COVID-19 Antibody Panel.

Full Story: 360Dx (tiered subscription model) (6/23)

	COVID-19 and the "new normal" Wide-ranging changes have already been seen in the MedTech industry and commercial model. To move forward companies will need to evaluate all available resources and not be hesitant to change and innovate. Download the whitepaper to understand how to demonstrate your value quickly.

Science & Health

Preoperative MRI boosts cancer identification in DCIS

A study in the European Journal of Radiology found that preoperative breast MRI was able to identify 11.2% more cancer sites in women with ductal carcinoma in situ, and while those with additional cancers on preoperative MRI had higher initial mastectomy rates than those who didn't undergo preoperative MRI, both groups had similar re-excision rates. The findings prompted researchers to support the use of preoperative MRI among women with DCIS.

Full Story: AuntMinnie (free registration) (6/24)

Magnetic eyelashes not safe for MR imaging

Researchers found that ferromagnetic eyelashes had deflection angles significantly greater than 45 degrees and heavier magnetic lashes may have a bigger projectile effect, indicating that they are unsafe to use during MR imaging. The findings, published in the Journal of Applied Clinical Medical Physics, prompted researchers to recommend that patients remove their magnetic eyelashes prior to entering Zone 3, or the pre-MRI scanner area.

Full Story: Radiology Business (6/23)

Emerging Technologies

CytoSorbents launches blood purification tech

CytoSorbents has released its CytoSorb blood purification device, which is used to treat deadly inflammation, in Argentina, Colombia, Guatemala, Ecuador, Bolivia, El Salvador, the Dominican Republic, Costa Rica and Peru.

Full Story: Seeking Alpha (free registration) (6/24)

Researchers developing fast COVID-19 test

A COVID-19 test that can deliver results within 20 minutes and can be done at home is being developed by researchers from Iowa State University. The test is designed to detect a protein for the virus using urine or saliva.

Full Story: KCCI-TV (Des Moines, Iowa) (6/24)

Government & Regulatory

Astigmatism management tech from J&J Vision cleared

The FDA has given 510(k) clearance to Johnson & Johnson Vision for its CATALYS cOS 6.0, an astigmatism management software for its laser cataract surgery system that automatically compensates for cycloration and allows for a more accurate laser alignment.

Full Story: FDAnews (6/25)

COVID-19 tests from Laihe Biotech, Gencurix get EUA

The FDA has given emergency use authorization to Laihe Biotech for its Lyher Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit and to Gencurix for its GenePro SARS-CoV-2 Test.

Full Story: GenomeWeb Daily News (free registration) (6/24)

AdvaMed Events and Education

Advertising and Promotion of Medical Devices Webinar Series

While the current global health crisis prevents us from hosting this year's Advertising and Promotion of Medical Devices Conference, we are pleased to deliver some of the most timely content in a virtual format. This three-part webinar series will highlight essential topics, including AdvaMed's direct-to-consumer principles, current social media considerations and important legal and regulatory boundaries. Learn more.

New AdvaMed COVID-19 Resource Center now available

With our member companies on the front lines of the fight against the COVID-19 pandemic, AdvaMed is working diligently to address the medtech industry's needs and provide resources that support you and your businesses during this challenging time. To better support you, we have launched a new COVID-19 Resource Center to provide important information to companies about the federal response to COVID-19, best practices and other valuable resources. Learn more.